Zhen Wang
- Organic Chemistry top 0.2%
- Catalytic C–H Functionalization Methods 55
- Sulfur-Based Synthesis Techniques 29
- Synthesis and Catalytic Reactions 26
- Synthesis and biological activity 20
- Chemical Synthesis and Reactions 16
- Inorganic Chemistry top 2%
- Metal-Organic Frameworks: Synthesis and Applications 19
- Molecular Biology top 2%
- Cancer therapeutics and mechanisms 22
- Biochemistry top 1%
- Toxicology top 1%
-
- Cancer Mechanisms and Therapy 19
Zhen Wang
462 papers receiving 9.6k citations
Peers
Comparison fields: 5 of 165
- Organic Chemistry 3.7k
- Inorganic Chemistry 814
- Molecular Biology 3.5k
- Biochemistry 322
- Toxicology 144
Countries citing papers authored by Zhen Wang
This map shows the geographic impact of Zhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Wang more than expected).
Fields of papers citing papers by Zhen Wang
This network shows the impact of papers produced by Zhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Wang. The network helps show where Zhen Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 5 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 11 | |
| 15 | 2022 | 86 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 11 | |
| 18 | 2013 | 258 | |
| 19 | 2012 | 276 | |
| 20 | [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis]. | 2006 | 4 |
About Zhen Wang
Zhen Wang is a scholar working on Organic Chemistry, Pharmacology, Inorganic Chemistry, Molecular Biology and Pharmacology, having authored 497 papers that have together received 9.7k indexed citations. Recurring topics across this work include Catalytic C–H Functionalization Methods (55 papers), Sulfur-Based Synthesis Techniques (29 papers), Synthesis and Catalytic Reactions (26 papers), Cancer therapeutics and mechanisms (22 papers), Synthesis and biological activity (20 papers), Cancer Mechanisms and Therapy (19 papers), Metal-Organic Frameworks: Synthesis and Applications (19 papers) and Chemical Synthesis and Reactions (16 papers). The work is most often cited by research in Organic Chemistry (3.7k citations), Inorganic Chemistry (814 citations), Molecular Biology (3.5k citations), Biochemistry (322 citations) and Toxicology (144 citations). Zhen Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yoichiro Kuninobu, Motomu Kanai, Tao Shi, Honghua Zhang, Jizhi Ni, Sukbok Chang, Donggun Lee, Taek Kang, Youngchan Kim and Quanyi Zhao. Their work appears in journals such as European Journal of Medicinal Chemistry, Organic Letters, Organic & Biomolecular Chemistry, Organic Chemistry Frontiers and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.